Virus Filtration Market By Product (Kits, Reagents & Consumables, Filtration Systems, and Services), By Application (Biological (Vaccines & Therapeutics, Blood & Blood Products, Cellular & Gene Therapy Products, Tissue & Tissue Products, and Stem Cell Products), Medical Devices, Water Purification, and Air Purification), By End-user (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs), Academic Research Organizations, and Medical Device Companies), and By Region - Trends, Analysis and Forecast till 2034

Virus Filtration Market accounted for USD 820.4 Million in 2024 and is estimated to be USD 1843.7 Million by 2034 and is anticipated to register a CAGR of 8.40%.

Viruses are small infectious particles or agents. They are undesired, especially in the pharmaceuticals industry, which needs to be removed for drug sterility. Filtration is a process to remove viruses. It offers advantages such as easy operability and slight damage to the products. Virus filtration is usually performed at the end of any process of the purification step. Virus filters act as a barrier or protecting medium for bioreactors by filtering buffer media and solutions. The growing pharmaceuticals industries and helping hands of government towards these biotechnology and pharmaceuticals industries play an important role in the growth of virus filtration market.

Growing prevalence of chronic diseases including diabetes, cancer, and autoimmune disorders is expected to drive demand for biologics. According to data published by the International Agency for Research on Cancer, about 14.1 million new cases of cancer were diagnosed worldwide in 2012 and this number is estimated to reach 21.7 million by 2030. Thus, there is an increasing demand for therapeutic biologics, which subsequently propels the demand for virus filtration products for manufacturing and R&D applications. Compliance with production regulatory frameworks such as Current Good Manufacturing Practice (cGMP) regulations and drug development is another main factor projected to boost the target market growth. Moreover, CROs are collaborating with biopharmaceutical and biotechnology companies for the development of novel therapy and drug, which is also expected to support global market growth. Service providers including Lonza Group Ltd., Charles River Laboratories International, Inc., and WuXi PharmaTech provide virus clearance services for pharmaceutical and biopharmaceutical companies. Thus, growth in the outsourcing industry is a lucrative opportunity which may propel the growth of the global virus filtration market. However, stringent regulations for validation of filtration products is the major factor hampering the growth of the target market.

Virus filtration market is segmented based on product, application, end-user, and region.

Based on product, the global virus filtration market is segmented into kits, reagents & consumables, filtration systems, and services. In 2018, the kits, reagents & consumables product segment estimated for the largest share of the virus filtration market and is projected to maintain its dominance over the forecast period owing to the increased usage of these products for virus filtration. Based on application, the global market is classified into biological medical devices, water purification, and air purification. Biological medical devices are sub-divided into vaccines & therapeutics, blood & blood products, cellular & gene therapy products, tissue & tissue products, and stem cell products. Based on end-user, the target market is segmented into pharmaceutical and biotechnology companies, contract research organizations (CROs), academic research organizations, and medical device companies.

Based on the region the global virus filtration market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2018, North America dominated the target market and is expected to maintain its dominance over the forecast period. The well-established biopharmaceutical and biotechnology industry in the U.S. has spurred the demand for advanced viral clearance products for biologics production and R&D in this region. Europe was the second-largest market, owing to the high demand for innovative virus filtration products for biologics development and production along with research. Asia-pacific is anticipated to register the highest CAGR during the forecast period due to the increasing number of road accidents and trauma cases. Presence of lucrative growth opportunities in the rapidly growing Asian economies such as India, China, and Indonesia is valued to propel the regional growth.

Virus Filtration Market, By Product:

• Kits, Reagents & Consumables
• Filtration Systems
• Services

Virus Filtration Market, By Application:

• Biological

• Vaccines & Therapeutics
• Blood & Blood Products
• Cellular & Gene Therapy Products
• Tissue & Tissue Products
• Stem Cell Products

• Medical Devices
• Water Purification
• Air Purification

Virus Filtration Market, By End-user:

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Academic Research Organizations
• Medical Device Companies

Virus Filtration Market, By Region:

• North America
  • Middle East & Africa
    • Middle East & Africa Virus Filtration Market, By Product
    • Middle East & Africa Virus Filtration Market, By Application
    • Middle East & Africa Virus Filtration Market, By End-user
    • Middle East & Africa Virus Filtration Market, By Country
      • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • Latin America Virus Filtration Market, By Product
    • Latin America Virus Filtration Market, By Application
    • Latin America Virus Filtration Market, By End-user
    • Latin America Virus Filtration Market, By Country
      • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • Asia Pacific Virus Filtration Market, By Product
    • Asia Pacific Virus Filtration Market, By Application
    • Asia Pacific Virus Filtration Market, By End-user
    • Asia Pacific Virus Filtration Market, By Country
      • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • Europe Virus Filtration Market, By Product
    • Europe Virus Filtration Market, By Application
    • Europe Virus Filtration Market, By End-user
    • Europe Virus Filtration Market, By Country
      • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • North America Virus Filtration Market, By Product
  • North America Virus Filtration Market, By Application
  • North America Virus Filtration Market, By End-user
  • North America Virus Filtration Market, By Country
    • The U.S.
    • Canada

The key players operating the global virus filtration market involves Asahi Kasei Medical Co. Ltd., Charles River Laboratories International Inc., General Electric Company, Lonza Group Ltd., Merck KgaA, Pall Corporation, Sartorius AG, Clean Cell Inc., Thermo Fischer Scientific Inc., and Wuxi Biologics. Prominent players operating in the target market are focusing on strategic partnerships as well as the launching of the Product to gain a competitive edge in the target market. For instance, in March 2019, Lonza Group Ltd expanded mycoplasma detection portfolio, with a new luminometer, which is designed to accelerate and simplify testing

• Asahi Kasei Medical Co. Ltd.
• Charles River Laboratories International, Inc.
• General Electric Company
• Lonza Group, Ltd.
• Merck KgaA
• Pall Corporation
• Sartorius AG
• Clean Cell, Inc.
• Thermo Fischer Scientific, Inc.
• Wuxi Biologics